David Craig Wright is an accomplished inventor based in Pacific Grove, California. He holds two patents that showcase his contributions to the fields of vaccine development and topical formulations. His work reflects a commitment to advancing medical science and improving health outcomes.

Latest Patents

Wright's latest patents include "Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use." This invention involves adjuvanted protein vaccines that comprise a modified S1 Spike protein sequence of the SARS-CoV-2 variant C.1.2, encapsulated within a non-phospholipid liposome. These vaccines are designed for subcutaneous administration and offer methods of use for the modified spike protein sequences.

Another significant patent is "Topical formulations including lipid microcapsule delivery vehicles and their uses." This invention relates to topical formulations that utilize lipid microcapsules made from tocopherol, tocotrienol, or their mixtures. The formulations are capable of delivering transdermal active agents, such as vitamin D, through the skin and into the bloodstream without the need for skin penetration enhancers. Additionally, they can deliver topical active agents to the skin's surface.

Career Highlights

Throughout his career, Wright has worked with notable companies such as D4 Labs, LLC and Avidas Pharmaceuticals, LLC. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Wright has collaborated with professionals like Michael Bowe and Emily Wright, enhancing his work through shared knowledge and expertise.

Conclusion

David Craig Wright's innovative patents and career achievements highlight his significant contributions to medical science. His work continues to pave the way for advancements in vaccine technology and topical formulations.

This text is generated by artificial intelligence and may not be accurate.